Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Capital Leases (2020 - 2025)

Ptc Therapeutics (PTCT) has 6 years of Capital Leases data on record, last reported at $3.0 million in Q4 2025.

  • For Q4 2025, Capital Leases fell 80.74% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $3.0 million, down 80.74%, while the annual FY2025 figure was $3.0 million, 80.74% down from the prior year.
  • Capital Leases reached $3.0 million in Q4 2025 per PTCT's latest filing, down from $13.8 million in the prior quarter.
  • Across five years, Capital Leases topped out at $20.1 million in Q4 2021 and bottomed at $3.0 million in Q4 2025.
  • Average Capital Leases over 5 years is $15.9 million, with a median of $17.2 million recorded in 2023.
  • Peak YoY movement for Capital Leases: decreased 7.09% in 2022, then crashed 80.74% in 2025.
  • A 5-year view of Capital Leases shows it stood at $20.1 million in 2021, then dropped by 7.09% to $18.7 million in 2022, then dropped by 7.98% to $17.2 million in 2023, then dropped by 9.37% to $15.6 million in 2024, then plummeted by 80.74% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Leases were $3.0 million in Q4 2025, $13.8 million in Q3 2025, and $13.8 million in Q2 2025.